How tobacco control policies affect the risks of tobacco use and electronic cigarettes.
The Interplay of ENDS and Tobacco Control Policy: Impact on the Population Harms of Tobacco
This study looks at how e-cigarettes and other vaping products affect public health and how stronger tobacco control rules, like higher taxes and smoking bans, can help reduce the harm from smoking, so we can better understand the risks and benefits of using these products compared to regular cigarettes.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Healthpartners Institute NIH-funded |
| Lab location | 1 site (Bloomington, UNITED STATES) |
| Project ID | NIH-10888367 on NIH RePORTER |
What this research studies
This research investigates the impact of electronic nicotine delivery systems (ENDS), like e-cigarettes, on public health in relation to tobacco control policies. It aims to understand how these policies can reduce the overall harms caused by tobacco use, particularly by comparing the risks of ENDS to traditional combustible cigarettes. The study will utilize simulation models to analyze the effects of intensified tobacco control policies, such as increased taxes and comprehensive smoking bans, on population health outcomes. By evaluating these factors, the research seeks to clarify the potential benefits and risks associated with ENDS in the context of existing tobacco control measures.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals aged 21 and older who use tobacco products or are at risk of tobacco use.
Not a fit: Patients who do not use tobacco products or have no interest in tobacco cessation may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective tobacco control policies that significantly reduce health risks associated with tobacco use.
How similar studies have performed: Previous research has shown that effective tobacco control policies can significantly reduce tobacco-related harms, suggesting that this approach has potential for success.
Where this research is happening
Bloomington, UNITED STATES
- Healthpartners Institute — Bloomington, United States (Active)
Researchers
- Principal investigator: Maciosek, Michael V — Healthpartners Institute
- Study coordinator: Maciosek, Michael V
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.